A
Axis Heilsa S. de R.L. de C.V. | Althian Clinical Research
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Gadopiclenol
Anastrozole
Talazoparib
Enzalutamide
Exemestane
Imlunestrant
Tamoxifen
Sunitinib
Cabozantinib
Letrozole
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...
Enrolling
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen
The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatme...
Active, not recruiting
Carcinoma, Squamous Cell, Non-small-cell Lung
Drug: Olaparib
Drug: Paclitaxel
The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...
Active, not recruiting
Prostate Cancer
Drug: Placebo plus enzalutamide
Drug: talazoparib plus enzalutamide
Trial sponsors
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems